Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours Β· Estimated delivery Aug 18 - Aug 23
Rather than stopping GLP-1 therapy (which may be life-saving for diabetes, obesity, and cardiovascular risk), sexual medicine is beginning to treat the neurochemical side effect directly
The author(s) declared that they were an editorial board member of Frontiers, at the time of submission
GLP-1 receptor agonists are not currently recommended for use during breastfeeding due to insufficient safety data in lactating populations
Neuroprotection and brain injury repair&Research on metabolic disease models Cerebral ischemia model: After occlusion of the middle cerebral artery (MCAO) in rats, injection of IGF-1 LR3 (10 g/kg) into the lateral ventricle can: Reduce the area of neuronal death by 30%
US$ 25.91
US$ 27.43
US$ 25.53
US$ 22.89
US$ 25.76
US$ 20.93
US$ 28.04
